Literature DB >> 22133899

Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation.

J G Mainz1, J Hentschel, C Schien, N Cramer, W Pfister, J F Beck, B Tümmler.   

Abstract

UNLABELLED: We report on two CF patients who received double lung transplantation (LTX) due to Pseudomonas aeruginosa related pulmonary destruction. Prior to LTX we detected P. aeruginosa in nasal lavages (NL) and sputum cultures from both patients. Donor lungs of patient 1 became colonized within four weeks with P. aeruginosa identical in genotype with isolates from his pre-transplant sputum cultures and pre- and post-transplant NL. In contrast, patient 2 remained P. aeruginosa free in lower airway samples (bronchial lavage/sputum) for now up to 30 months, despite persistent detection of P. aeruginosa that was identical in genotype with pre-transplant NL and sputum isolates in NL and even in throat swabs. For prevention of pulmonary re-colonization patient 2 has continuously inhaled Colomycin 1 MIU once daily during the preceding more than 36 months with the novel Pari Sinus™ nebulizer, which in scintigraphic studies was shown to deliver vibrating aerosols into paranasal sinuses, additional to bronchial antibiotic inhalation. DISCUSSION: Pulmonary colonization of transplanted donor lungs with identical clones previously colonizing the explanted lungs has been described previously and the upper airways were postulated as reservoir for descending colonization. However, this remained speculative, as upper airway sampling which does not belong to current standards, was not performed in these studies. Our report demonstrates persistence of identical P. aeruginosa genotypes in CF upper airways prior to and after LTX underlining risks of descending colonization of transplanted lungs with P. aeruginosa, which increases risks of graft dysfunction. Therefore, we recommend regular assessment of sinonasal colonization prior to and after LTX. Sinonasal inhalation with antimicrobials should be investigated in prospective trials. Copyright Â
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22133899     DOI: 10.1016/j.jcf.2011.10.009

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  17 in total

Review 1.  [Specific infections in organ transplantation].

Authors:  M Cornberg; B Schlevogt; J Rademacher; A Schwarz; M Sandherr; G Maschmeyer
Journal:  Internist (Berl)       Date:  2016-01       Impact factor: 0.743

Review 2.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

Review 3.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

4.  Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation.

Authors:  Siddhartha G Kapnadak; Gregory A Kicska; Kathleen J Ramos; Desiree A Marshall; Tamara Y Carroll; Sudhakar N Pipavath; Michael S Mulligan; Christopher H Goss; Moira L Aitken
Journal:  J Cyst Fibros       Date:  2017-07-28       Impact factor: 5.482

5.  Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.

Authors:  Rocio Rivas Caldas; Florence Le Gall; Krista Revert; Gilles Rault; Michèle Virmaux; Stephanie Gouriou; Geneviève Héry-Arnaud; Georges Barbier; Sylvie Boisramé
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

6.  16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients.

Authors:  Sarah K Lucas; Robert Yang; Jordan M Dunitz; Holly C Boyer; Ryan C Hunter
Journal:  J Cyst Fibros       Date:  2017-08-18       Impact factor: 5.482

Review 7.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

8.  Smell in cystic fibrosis.

Authors:  J Lindig; C Steger; N Beiersdorf; R Michl; J F Beck; T Hummel; J G Mainz
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-14       Impact factor: 2.503

9.  Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.

Authors:  Wibke Katharina Janhsen; Christin Arnold; Julia Hentschel; Thomas Lehmann; Wolfgang Pfister; Michael Baier; Klas Böer; Kerstin Hünniger; Oliver Kurzai; Uta-Christina Hipler; Jochen Georg Mainz
Journal:  Med Microbiol Immunol       Date:  2016-07-04       Impact factor: 3.402

Review 10.  [Rhinosinusitis in cystic fibrosis].

Authors:  J G Mainz; A Gerber; C Arnold; J Baumann; I Baumann; A Koitschev
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.